BioNTech SE
BNTX
$92.80
-$0.87-0.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -11.05% | -87.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.05% | -87.17% | |||
| Cost of Revenue | 35.14% | -76.75% | |||
| Gross Profit | -81.68% | -92.39% | |||
| SG&A Expenses | 30.48% | -31.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 827.26% | -89.33% | |||
| Total Operating Expenses | 19.18% | -34.90% | |||
| Operating Income | -24.42% | -121.86% | |||
| Income Before Tax | -50.36% | -146.28% | |||
| Income Tax Expenses | -4.15% | -145.99% | |||
| Earnings from Continuing Operations | -53.50% | -71.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -53.50% | -71.92% | |||
| EBIT | -24.42% | -121.86% | |||
| EBITDA | -4.10% | -106.69% | |||
| EPS Basic | -53.48% | -65.62% | |||
| Normalized Basic EPS | -36.22% | -161.15% | |||
| EPS Diluted | -53.48% | -65.62% | |||
| Normalized Diluted EPS | -36.22% | -161.15% | |||
| Average Basic Shares Outstanding | 0.02% | 3.81% | |||
| Average Diluted Shares Outstanding | 0.02% | 3.81% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||